Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

CG Oncology (CGON) Shares Issued (2023 - 2025)

CG Oncology filings provide 3 years of Shares Issued readings, the most recent being -$42.5 million for Q4 2025.

On a quarterly basis, Shares Issued fell 119.07% to -$42.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.9 million, a 98.91% decrease, with the full-year FY2025 number at $6.5 million, down 98.41% from a year prior.
Shares Issued hit -$42.5 million in Q4 2025 for CG Oncology, down from $48.7 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $406.4 million in Q1 2024 to a low of -$406.3 million in Q2 2024.
Median Shares Issued over the past 3 years was $472000.0 (2023), compared with a mean of $53.2 million.
The widest YoY moves for Shares Issued: up 597561.76% in 2024, down 246362.42% in 2024.
CG Oncology's Shares Issued stood at $262000.0 in 2023, then surged by 85052.67% to $223.1 million in 2024, then plummeted by 119.07% to -$42.5 million in 2025.
The last three reported values for Shares Issued were -$42.5 million (Q4 2025), $48.7 million (Q3 2025), and $19000.0 (Q2 2025) per Business Quant data.